UK Markey Cancer Center Awarded $6 Million Dollar Grant

May 16, 2012

LEXINGTON, Ky. - The University of Kentucky Markey Cancer Center will be receiving a $6 million dollar grant to investigate a disorder sometimes caused by chemotherapy and radiation treatments. The announcement was made at the annual Markey Cancer Research Day.

Students and professors observe the research displays lining the hallways of UK’s Singletary Center.  

"Whatever you can cram onto a five foot by four foot poster, hopefully somebody can come by, look at it, and get a quick message," says Kyle Rector, a grad student at UK working with stem cells.

Rector says Research Day allows for new collaborations as well as a chance to celebrate the progress that’s already been made. This year, the Markey Cancer Center has been awarded a $6 million dollar grant to study Myelodysplasia, a blood and bone marrow disease that can result from therapies used to treat cancer. Markey Cancer Center director Dr. Mark Evers says the center also hopes to gain NCI – or National Cancer Institute – status next year.

"It really puts us in terms of the best of the best of the cancer centers that are expected to be making the big discoveries like this grant will fuel," Evers says.

Researchers hope the grant will allow them to identify who is most at risk for myelodyplasia and adjust treatment accordingly.